Byrne Asset Management’s GSK GSK Stock Holding History

Byrne Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.94K	Hold	56	–	–	﹤0.01%	535
2026 Q1	$3.09K	Hold	56	–	–	﹤0.01%	505
2025 Q4	$2.75K	Hold	56	–	–	﹤0.01%	507
2025 Q3	$2.42K	Hold	56	–	–	﹤0.01%	515
2025 Q2	$2.15K	Hold	56	–	–	﹤0.01%	503
2025 Q1	$2.17K	Hold	56	–	–	﹤0.01%	520
2024 Q4	$1.89K	Hold	56	–	–	﹤0.01%	508
2024 Q3	$2.29K	Sell	56 -90	-62%	-$3.68K	﹤0.01%	499
2024 Q2	$5.64K	Buy	146 +90	+161%	+$3.79K	﹤0.01%	436
2024 Q1	$2.4K	Hold	56	–	–	﹤0.01%	486
2023 Q4	$2.08K	Hold	56	–	–	﹤0.01%	494
2023 Q3	$2K	Hold	56	–	–	﹤0.01%	474
2023 Q2	$2K	Hold	56	–	–	﹤0.01%	541
2023 Q1	$2K	Buy	+56	New	+$1.96K	﹤0.01%	545
2022 Q3	–	Sell	-82	Closed	-$4K	–	511
2022 Q2	$4K	Buy	+82	New	+$4.53K	﹤0.01%	447

Other funds holding GSK

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

KFP

Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return

KIC

Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

AWAG

ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return

HAI

Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return

Byrne Asset Management's GSK Position: Q2 2026 in Review

Byrne Asset Management held its GSK (GSK) position steady in Q2 2026 at 56 shares worth $2.94K. The position accounts for ﹤0.01% of the portfolio, ranked #535.

Byrne Asset Management first reported a position in GSK in Q2 2022 and has held it in 15 quarters since. The position peaked at $5.64K in Q2 2024. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Byrne Asset Management held 56 shares of GSK worth $2.94K as of Q2 2026.
Byrne Asset Management left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of Byrne Asset Management's portfolio in Q2 2026, its #535 holding.
Byrne Asset Management first reported a position in GSK in Q2 2022 and has held it in 15 quarters since.
Byrne Asset Management's GSK position peaked at $5.64K in Q2 2024.
161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.